PANAGORA ASSET MANAGEMENT INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$209,000
-31.2%
114,014
+0.0%
0.00%
-50.0%
Q1 2022$304,000
-37.8%
114,005
+0.9%
0.00%
-33.3%
Q4 2021$489,000
-14.8%
112,933
+0.1%
0.00%0.0%
Q3 2021$574,000
-3.2%
112,816
+20.4%
0.00%0.0%
Q2 2021$593,000
+238.9%
93,693
+312.9%
0.00%
+200.0%
Q1 2021$175,000
-72.9%
22,693
-77.0%
0.00%
-75.0%
Q4 2020$645,000
-64.3%
98,481
-63.8%
0.00%
-63.6%
Q3 2020$1,807,000
-39.8%
271,733
-24.6%
0.01%
-42.1%
Q2 2020$3,004,000
+11.1%
360,600
+2.3%
0.02%0.0%
Q1 2020$2,704,000
-32.6%
352,584
-26.9%
0.02%
+5.6%
Q4 2019$4,010,000
+472.9%
482,537
+640.6%
0.02%
+500.0%
Q1 2019$700,000
-47.6%
65,159
-26.4%
0.00%
-50.0%
Q4 2018$1,337,000
-59.9%
88,530
-50.9%
0.01%
-53.8%
Q3 2018$3,334,000
-32.4%
180,239
-16.5%
0.01%
-35.0%
Q2 2018$4,932,000
+9.0%
215,748
+35.7%
0.02%
+11.1%
Q1 2018$4,524,000
+14.2%
159,014
-15.3%
0.02%
+20.0%
Q4 2017$3,961,000
+73.2%
187,657
+49.1%
0.02%
+66.7%
Q3 2017$2,287,000
+17.2%
125,8900.0%0.01%
+12.5%
Q2 2017$1,951,000
+195000.0%
125,890
+224703.6%
0.01%
Q1 2017$1,000560.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders